000 01121 a2200241 4500
005 20250516091109.0
264 0 _c20120514
008 201205s 0 0 eng d
022 _a1477-092X
024 7 _a10.1177/1078155212439813
_2doi
040 _aNLM
_beng
_cNLM
245 0 0 _aAbstracts of the XIII Symposium of the International Society of Oncology Pharmacy Practitioners. May 9-11, 2012. Melbourne, Australia.
_h[electronic resource]
260 _bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_cJun 2012
300 _a3-24 p.
_bdigital
500 _aPublication Type: Congress; Overall
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMedical Oncology
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPharmacy
773 0 _tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_gvol. 18
_gno. 2 Suppl
_gp. 3-24
856 4 0 _uhttps://doi.org/10.1177/1078155212439813
_zAvailable from publisher's website
999 _c21742229
_d21742229